Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Hetty A van den Berg"'
Autor:
An-Sofie E. Verrijssen, Wim J.F. Dries, Jeltsje S. Cnossen, Jacqueline Theuws, Heike M.U. Peulen, Hetty A. van den Berg, Dorien C. Rijkaart, Eva L.K. Voogt, Inger-Karine Kolkman-Deurloo, Joost Nuyttens, Harm J.T. Rutten, Jacobus W.A. Burger, Cathryn Huibregtse Bimmel-Nagel
Publikováno v:
Journal of Contemporary Brachytherapy, Vol 14, Iss 4, Pp 370-378 (2022)
Externí odkaz:
https://doaj.org/article/a333e3826f5b4d0687c9ba54f54ae5b8
Autor:
Cornelis D. de Kroon, Annerie Slot, Jannet C. Beukema, Tanja C. Stam, Judith R. Kroep, Hetty A. van den Berg, Ina M. Jürgenliemk-Schulz, Cathalijne C.B. Post, Jan Willem M. Mens, Ludy C.H.W. Lutgens, F. Koppe, Marie A.D. Haverkort, Ellen M.A. Roeloffzen, An Snyers, Carien L. Creutzberg, Eva E. Schaake, Anne M. Stiggelbout, Hans W. Nijman
Publikováno v:
Gynecologic Oncology, 161(3), 727-733
Gynecologic Oncology, 161(3), 727-733. ACADEMIC PRESS INC ELSEVIER SCIENCE
Gynecologic Oncology, 161(3), 727-733. Academic Press
Gynecologic Oncology, 161, 727-733
Gynecologic Oncology, 161(3), 727-733. Elsevier Science
Gynecologic Oncology, 161, 3, pp. 727-733
Gynecologic Oncology, 161(3), 727-733. ACADEMIC PRESS INC ELSEVIER SCIENCE
Gynecologic Oncology, 161(3), 727-733. Academic Press
Gynecologic Oncology, 161, 727-733
Gynecologic Oncology, 161(3), 727-733. Elsevier Science
Gynecologic Oncology, 161, 3, pp. 727-733
Background. Decision making regarding adjuvant therapy for high-risk endometrial cancer is complex. The aim of this study was to determine patients' and clinicians' minimally desired survival benefit to choose chemoradiotherapy over radiotherapy alon
Autor:
Eline H. Huele, Maureen J.B. Aarts, Jacqueline M. Tromp, Michael Schaapveld, Ronald de Wit, Hetty A van den Berg, J. Alfred Witjes, Jourik A. Gietema, Tineke J. Smilde, Harmke J. Groot, Ben G. L. Vanneste, Gerard Groenewegen, J.L.H. Ruud Bosch, Janine Nuver, Simon Horenblas, Richard P. Meijer, Peter De Brouwer, Joost M. Blok
Publikováno v:
Journal of Clinical Oncology, 39, 4, pp. 319-327
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 39(4), 319-327. American Society of Clinical Oncology
Journal of clinical oncology, 39(4), 319-327. American Society of Clinical Oncology
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 39(4):JCO2002352, 319-330. AMER SOC CLINICAL ONCOLOGY
Journal of Clinical Oncology, 39(4), 319-+. American Society of Clinical Oncology
Journal of Clinical Oncology, 39, 319-327
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 39(4), 319-327. American Society of Clinical Oncology
Journal of clinical oncology, 39(4), 319-327. American Society of Clinical Oncology
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 39(4):JCO2002352, 319-330. AMER SOC CLINICAL ONCOLOGY
Journal of Clinical Oncology, 39(4), 319-+. American Society of Clinical Oncology
Journal of Clinical Oncology, 39, 319-327
PURPOSE Patients with testicular germ cell tumor (TGCT) are at increased risk of developing a contralateral TGCT (CTGCT). Although some studies suggest that prior treatment with platinum-based chemotherapy affects CTGCT risk, a relationship between C
Autor:
Nanda Horeweg, Stefan Kommoss, Ludy C.H.W. Lutgens, Katrien Vandecasteele, Marlies E. Nowee, Remi A. Nout, C. Gillham, Bastiaan G Wortman, F. Koppe, Hetty A. van den Berg, Tjalling Bosse, David Cibula, Karen W Verhoeven-Adema, Annerie Slot, Hein Putter, Cyrus Chargari, Ina M. Jürgenliemk-Schulz, Veronique L M A Coen, Aleida G Zwanenburg, Hans W. Nijman, Carien L. Creutzberg, Elzbieta van der Steen-Banasik, Tanja C. Stam, G Henrieke Westerveld, Anne Sophie V M van den Heerik, Wilbert B. van den Hout, Jan Willem M. Mens, An Snyers, Moritz Hamann, Stefan Bijmolt
Publikováno v:
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2020(30), 2002-2007. BMJ Publishing Group
International journal of gynecological cancer, 30(12), 2002-2007. Wolters Kluwer Health
International Journal of Gynecological Cancer, 30, 12, pp. 2002-2007
International Journal of Gynecological Cancer, 30(12), 2002-2007. BMJ Publishing Group
International Journal of Gynecological Cancer
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
International Journal of Gynecological Cancer, 30, 2002-2007
International Journal of Gynecological Cancer, 30(12), 2002-2007. LIPPINCOTT WILLIAMS & WILKINS
International journal of gynecological cancer, 30(12), 2002-2007. Wolters Kluwer Health
International Journal of Gynecological Cancer, 30, 12, pp. 2002-2007
International Journal of Gynecological Cancer, 30(12), 2002-2007. BMJ Publishing Group
International Journal of Gynecological Cancer
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
International Journal of Gynecological Cancer, 30, 2002-2007
International Journal of Gynecological Cancer, 30(12), 2002-2007. LIPPINCOTT WILLIAMS & WILKINS
BackgroundVaginal brachytherapy is currently recommended as adjuvant treatment in patients with high-intermediate risk endometrial cancer to maximize local control and has only mild side effects and no or limited impact on quality of life. However, t
Autor:
Peter De Brouwer, Gerard Groenewegen, Richard P. Meijer, Janine Nuver, Harmke J. Groot, Joost M. Blok, Jourik A. Gietema, Ruud Bosch, Ronald de Wit, Hetty A van den Berg, Jacqueline M. Tromp, Alfred Witjes, Maureen J.B. Aarts, Tineke J. Smilde, Michael Schaapveld, Simon Horenblas, Ben G. L. Vanneste
Publikováno v:
Journal of Urology. 203
INTRODUCTION AND OBJECTIVE:Patients with testicular germ cell tumor (TGCT) are at increased risk of developing a metachronous contralateral testicular germ cell tumor (CTGCT). It is unclear whether...
Autor:
Ronald de Wit, Sjoukje Lubberts, Michael Schaapveld, O. W. M. Meijer, Simon Horenblas, Igle J. de Jong, Tineke J. Smilde, Alexandra W. van den Belt-Dusebout, Jourik A. Gietema, Hetty A van den Berg, Ben G. L. Vanneste, Gerard Groenewegen, Maarten C.C.M. Hulshof, Maureen J.B. Aarts, Harmke J. Groot, Katarzyna Jóźwiak, Philip Poortmans, J. Alfred Witjes, Flora E. van Leeuwen
Publikováno v:
Cancer, 126(3), 628-639. Wiley
Cancer, 126(3), 628-639. John Wiley and Sons Inc.
Cancer, 126, 628-639
Groot, H J, van Leeuwen, F E, Lubberts, S, Horenblas, S, de Wit, R, Witjes, J A, Groenewegen, G, Poortmans, P M, Hulshof, M C C M, Meijer, O W M, de Jong, I J, van den Berg, H A, Smilde, T J, Vanneste, B G L, Aarts, M J B, Jóźwiak, K, van den Belt-Dusebout, A W, Gietema, J A & Schaapveld, M 2020, ' Platinum exposure and cause-specific mortality among patients with testicular cancer ', Cancer, vol. 126, no. 3, pp. 628-639 . https://doi.org/10.1002/cncr.32538
Cancer, 126(3), 628. John Wiley and Sons Inc.
Cancer, 126, 3, pp. 628-639
Cancer, 126, 628-639. John Wiley & Sons Inc.
Cancer
Cancer, 126(3), 628-639. John Wiley and Sons Inc.
Cancer, 126, 628-639
Groot, H J, van Leeuwen, F E, Lubberts, S, Horenblas, S, de Wit, R, Witjes, J A, Groenewegen, G, Poortmans, P M, Hulshof, M C C M, Meijer, O W M, de Jong, I J, van den Berg, H A, Smilde, T J, Vanneste, B G L, Aarts, M J B, Jóźwiak, K, van den Belt-Dusebout, A W, Gietema, J A & Schaapveld, M 2020, ' Platinum exposure and cause-specific mortality among patients with testicular cancer ', Cancer, vol. 126, no. 3, pp. 628-639 . https://doi.org/10.1002/cncr.32538
Cancer, 126(3), 628. John Wiley and Sons Inc.
Cancer, 126, 3, pp. 628-639
Cancer, 126, 628-639. John Wiley & Sons Inc.
Cancer
Background Although testicular cancer (TC) treatment has been associated with severe late morbidities, including second malignant neoplasms (SMNs) and ischemic heart disease (IHD), cause‐specific excess mortality has been rarely studied among patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11e91b836123a14cbb96ff238908c8cb
https://cris.maastrichtuniversity.nl/en/publications/93b4dad2-5b86-489e-9df0-7b83bbf501c0
https://cris.maastrichtuniversity.nl/en/publications/93b4dad2-5b86-489e-9df0-7b83bbf501c0
Autor:
Petronella B. Ottevanger, Casper Reijnen, Maaike A. van der Aa, Johanna M.A. Pijnenborg, D. Boll, Hetty A. van den Berg, Florine A. Eggink, Willem Jan van Weelden
Publikováno v:
European Journal of Cancer, 133, pp. 104-111
European Journal of Cancer, 133, 104-111. ELSEVIER SCI LTD
European Journal of Cancer, 133, 104-111
European Journal of Cancer, 133, 104-111. ELSEVIER SCI LTD
European Journal of Cancer, 133, 104-111
Contains fulltext : 220441.pdf (Publisher’s version ) (Open Access) BACKGROUND: Patients with International Federation of Gynaecology and Obstetrics (FIGO) stage III endometrial cancer (EC) have a substantial risk of adverse outcomes. After surgery
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37fe6958f8fb2b9072ae18fa8c0ae521
https://hdl.handle.net/2066/220441
https://hdl.handle.net/2066/220441
Autor:
J. Steenhuijsen, Hetty A. van den Berg, Paul van Haaren, Katrien De Jaeger, Jeltsje Cnossen, Saskia Houterman, Kris Derks
Publikováno v:
Journal of Contemporary Brachytherapy
Purpose The purpose of this study was to analyze the effect of 2D conventional brachytherapy (CBT) compared to 3D MRI-guided brachytherapy (IGBT) with and without the use of interstitial needles on local control, overall survival, and toxicity in pat
Autor:
Geert-Jan Creemers, S.J. Bosman, Harm J. T. Rutten, Miranda Kusters, Grard A. P. Nieuwenhuijzen, Hetty A. van den Berg, Desley M. G. I. van Zoggel
Publikováno v:
Annals of Surgical Oncology, 23(6), 1883-1889. Springer, Cham
Lateral nodal disease is of major importance in the treatment of rectal cancer in the East, but a mostly neglected entity in the West. In this article, the treatment of recurrences in the lateral compartment (latLRs) in a national tertiary referral c
Autor:
Ruud Houben, Jacoba van der Zee, Hetty A. van den Berg, Gerard C. van Rhoon, Helena C. van Doorn, Ludy C.H.W. Lutgens, Peter C.M. Koper, Elzbieta van der Steen-Banasik, Jan J. Jobsen, Carien L. Creutzberg, Petronella B. Ottevanger
Publikováno v:
Radiotherapy and Oncology, 120, 378-382
Radiotherapy and Oncology, 120(3), 378-382. Elsevier Ireland Ltd
Radiotherapy and Oncology, 120(3), 378-382
Radiotherapy and Oncology, 120, 3, pp. 378-382
Radiotherapy and Oncology, 120(3), 378-382. Elsevier Ireland Ltd
Radiotherapy and Oncology, 120(3), 378-382
Radiotherapy and Oncology, 120, 3, pp. 378-382
Contains fulltext : 171329.pdf (Publisher’s version ) (Closed access) BACKGROUND: Chemoradiation (RT-CT) is standard treatment for locally advanced cervical cancer (LACC). This study tried to establish if radiotherapy combined with hyperthermia (RT